Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.

Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain types of cancer. They stimulate the immune system to respond against specific viruses, preventing future infections. In contrast, treatment vaccines are used to treat existing cancers by bolstering the immune system's ability to attack cancer cells. They are designed to target cancer-specific antigens, molecules found on cancer cells that can trigger an immune response.

Active cancer immunotherapies come in various forms, each with a unique method for stimulating the immune response to cancer cells. Whole-cell vaccines, like GVAX, use modified cancer cells to provoke an immune response. Tumor antigen vaccines, such as PROSTVAC, target specific antigens on cancer cells. Dendritic cell vaccines, such as Provenge, involve isolating a patient's dendritic cells, exposing them to cancer-specific antigens, and reintroducing them to the patient to stimulate a targeted immune response.

Research and development in the field of cancer vaccines continue to advance. Scientists are exploring novel vaccine strategies, such as personalized cancer vaccines that tailor treatment to individual patients' tumor profiles. Emerging research suggests that combining cancer treatment vaccines with other immunotherapies may enhance their effectiveness. For example, combining a cancer vaccine with checkpoint inhibitors, which help to overcome some cancers' ability to suppress the immune response, has shown promise in early studies.

In conclusion, cancer treatment vaccines represent an exciting and promising direction in cancer immunotherapy. By leveraging the body's natural defenses, these vaccines present a potentially powerful tool in the fight against cancer.

Tags
Cancer VaccinesImmunotherapyPreventive VaccinesTreatment VaccinesHuman Papillomavirus HPVImmune System StimulationCancer specific AntigensActive Cancer ImmunotherapiesWhole cell VaccinesTumor Antigen VaccinesDendritic Cell VaccinesPersonalized Cancer VaccinesCheckpoint InhibitorsCancer Treatment Strategies

Du chapitre 25:

article

Now Playing

25.38 : Cancer Vaccines

The Lymphatic and Immune System

162 Vues

article

25.1 : Introduction au système lymphatique et immunitaire

The Lymphatic and Immune System

1.2K Vues

article

25.2 : Fonctions du système lymphatique et immunitaire

The Lymphatic and Immune System

565 Vues

article

25.3 : Vaisseaux lymphatiques et transport lymphatique

The Lymphatic and Immune System

582 Vues

article

25.4 : Cellules et tissus lymphoïdes

The Lymphatic and Immune System

395 Vues

article

25.5 : Organes lymphoïdes primaires

The Lymphatic and Immune System

551 Vues

article

25.6 : Organes lymphoïdes secondaires

The Lymphatic and Immune System

450 Vues

article

25.7 : Structure et fonction détaillées des ganglions lymphatiques

The Lymphatic and Immune System

439 Vues

article

25.8 : Développement du système lymphatique

The Lymphatic and Immune System

174 Vues

article

25.9 : Introduction à l’immunité innée et adaptative

The Lymphatic and Immune System

2.2K Vues

article

25.10 : Barrières à membrane de surface

The Lymphatic and Immune System

483 Vues

article

25.11 : Cellules de la réponse immunitaire innée

The Lymphatic and Immune System

832 Vues

article

25.12 : Protéines antimicrobiennes

The Lymphatic and Immune System

528 Vues

article

25.13 : Système de complément

The Lymphatic and Immune System

1.4K Vues

article

25.14 : Surveillance immunitaire par les cellules NK et les phagocytes

The Lymphatic and Immune System

678 Vues

See More

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.